Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modelling in surgical oncology--part III: massive data sets and complex systems.

D A Rew1

  • 1Royal South Hants Cancer Centre, Southampton University Hospitals, UK.

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
|February 24, 2001
PubMed
Summary

Advanced computational approaches and biomathematics are revolutionizing the study of complex human tumors. This enables deeper insights into cancer biology and therapy by analyzing massive datasets with sophisticated mathematical tools.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The short life and times of assistant surgeon Donald E White.

Journal of the Royal Army Medical Corps·2012
Same author

Collective and corporate memory in the defence medical services.

Journal of the Royal Army Medical Corps·2011
Same author

Implementation of a short-stay programme after breast cancer surgery (Br J Surg 2010; 97: 189-194).

The British journal of surgery·2010
Same author

Research databases and data sets in cancer surgery.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2005
Same author

The sequencing of the rat genome.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2004
Same author

Surgical workload from an integrated UK field hospital during the 2003 Gulf conflict.

Journal of the Royal Army Medical Corps·2004

Area of Science:

  • Computational biology
  • Biomathematics
  • Tumor biology

Background:

  • Human tumors are inherently complex and unstable biological systems.
  • Traditional statistical methods are insufficient for analyzing the intricate data generated by modern biological research.
  • Advancements in computing power enable the analysis of massive datasets, including population health records and genomic data.

Purpose of the Study:

  • To explore the opportunities and challenges at the intersection of cell biology and biomathematics in modeling tumor complexity.
  • To highlight the transformative potential of computational approaches in understanding oncogenesis and cancer therapy.

Main Methods:

  • Utilizing sophisticated mathematical tools such as non-linear analysis, neural networks, chaos, and complexity theory.

Related Experiment Videos

  • Analyzing massive datasets, including medical, epidemiological, and genomic information.
  • Developing powerful computational models for closer representations of biological reality.

    • Main Results:

    • New intellectual and mathematical approaches, coupled with massive computing power, are enhancing the capacity to model and investigate tumor complexity.
    • Sophisticated mathematical tools are required to analyze complex biological systems, from protein construction to population interactions.
    • Computational models offer fresh perspectives on conventional statistics and aid in understanding oncogenesis and cancer therapy.

    Conclusions:

    • The integration of advanced computational methods and biomathematics is crucial for unraveling the complexity of human tumors.
    • This interdisciplinary approach promises significant advancements in cancer research, diagnosis, and treatment.
    • Further exploration of this interface is essential for future breakthroughs in tumor biology and personalized medicine.